Exclusive: Prasad 'wreaking havoc' at FDA as staff look for the exits

Under Prasad's leadership, employees at a key FDA center fear speaking out.

October 31, 2025 Check out STAT+

Sponsored By

Photo illustration: STAT; Photo: FDA STAT+ | Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits Prasad, the hired-fired-rehired head of the Center for Biologics Evaluation and Research, rattles FDA staff by expanding power, pushing out senior leaders. By Lizzy Lawrence Health care takes center stage in this year's elections, a sign of midterm strategies to come In Virginia and New Jersey, both parties are reframing health care around costs and access, a test run for national strategy ahead of the 2026 midterms. By Daniel Payne Judges order the Trump administration to use contingency funds for SNAP payments during the shutdown The judges in Massachusetts and Rhode Island gave the administration leeway on whether to fund SNAP partially or in full for November. By Associated Press David McNew/Getty Images Amid attacks on such work, NIH-led research links structural racism to increased heart disease NIH scientists publish research linking structural racism — a topic disfavored by agency leaders — to high blood pressure, obesity, diabetes By Anil Oza STAT+ | Insurers say they'll deploy more AI to combat 'aggressive' coding by hospitals As health care providers increase AI use in coding illness and filing claims, insurers turn to their own AI systems to fight 'aggressive' billing practices. By Katie Palmer Opinion: Proposed changes in Medicare coverage threaten access to procedures used to treat pain If approved, these Medicare coverage changes could drive chronic pain patients to opioids or invasive, expensive interventions. By Tricia Pendergrast Adobe Opinion: A $20 over-the-counter drug in Europe requires a prescription and $800 in the U.S. Pharma analyst David Maris examines the FDA process used by Bausch & Lomb to achieve a 40-fold price increase on a dry-eye drug. By David Maris

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser